Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any retinitis pigmentosa in which the cause of the disease is a mutation in the POMGNT1 gene.
Features include always present findings: Constriction of peripheral visual field, Nyctalopia, Reduced visual acuity, and Retinal thinning on OCT; and common findings: Bone spicule pigmentation of the retina and Peripapillary atrophy. 8 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Eyes | 3 | Hyperautofluorescent macular lesion, Cystoid macular edema, Retinal thinning on OCT |
POMGNT1 function has not been fully characterized.
Retinitis pigmentosa 76 is associated with mutations in the POMGNT1 gene on chromosome 1.
Genetic testing for POMGNT1 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for retinitis pigmentosa 76 has been reported in the published literature.
Phenotype severity distribution: 4 always present features, 2 common features.
No clinical trials have been registered for retinitis pigmentosa 76.
31 publications have been identified in PubMed for retinitis pigmentosa 76. Research spans Epidemiology / Natural History (39%), Diagnostic / Biomarker (13%), and Review / Meta-Analysis (13%).
Research Type | Count | % of Total |
|---|---|---|
Disease patterns and progression | 12 | 39% |
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 6:45 AM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Bones and joints |
1 |
Bone spicule pigmentation of the retina |
Muscles | 1 | Peripapillary atrophy |
4 |
13% |
Research summaries | 4 | 13% |
Patient case studies | 4 | 13% |
Clinical study results | 3 | 10% |
Laboratory research | 3 | 10% |
New treatment approaches | 1 | 3% |
Appelbaum T (2026). [PMID: 41649227](https://pubmed.ncbi.nlm.nih.gov/41649227/). *Invest Ophthalmol Vis Sci*. [Basic Science / Preclinical]
Durno NS (2026). [PMID: 41686418](https://pubmed.ncbi.nlm.nih.gov/41686418/). *Adv Ther*. [Epidemiology / Natural History]
Benites-Narcizo G (2026). [PMID: 42194903](https://pubmed.ncbi.nlm.nih.gov/42194903/). *J Clin Med*. [Review / Meta-Analysis]
Siqueira RC (2026). [PMID: 42158410](https://pubmed.ncbi.nlm.nih.gov/42158410/). *Cureus*. [Clinical Trial Publication]
Wiącek MP (2026). [PMID: 41750745](https://pubmed.ncbi.nlm.nih.gov/41750745/). *Diagnostics (Basel)*. [Epidemiology / Natural History]
Hashem SA (2025). [PMID: 39218074](https://pubmed.ncbi.nlm.nih.gov/39218074/). *Ophthalmol Retina*. [Epidemiology / Natural History]
Sharaf-Eldin W (2025). [PMID: 39998573](https://pubmed.ncbi.nlm.nih.gov/39998573/). *J Mol Neurosci*. [Review / Meta-Analysis]
Bae SH (2025). [PMID: 40007196](https://pubmed.ncbi.nlm.nih.gov/40007196/). *Korean J Ophthalmol*. [Diagnostic / Biomarker]
Gandoy-Fieiras N (2025). [PMID: 40993721](https://pubmed.ncbi.nlm.nih.gov/40993721/). *Orphanet J Rare Dis*. [Review / Meta-Analysis]
Asboth B (2025). [PMID: 41153429](https://pubmed.ncbi.nlm.nih.gov/41153429/). *Genes (Basel)*. [Epidemiology / Natural History]